{"id":"https://openalex.org/W47093099","doi":"https://doi.org/10.31083/ph.2012.1648","title":"Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC)","display_name":"Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC)","alternate_titles":[],"publication_year":2012,"publication_date":"2012-03-01","ids":{"openalex":"https://openalex.org/W47093099","doi":"https://doi.org/10.31083/ph.2012.1648","mag":"47093099","pmid":"https://pubmed.ncbi.nlm.nih.gov/22530305"},"language":"en","primary_location":{"id":"doi:10.31083/ph.2012.1648","doi":"https://doi.org/10.31083/ph.2012.1648","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2012.1648","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/67_03_S233_241.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W47093099"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://storage.imrpress.com/IMR/pharmazie/application/67_03_S233_241.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008248783","display_name":"Beate Bittner","orcid":"https://orcid.org/0000-0002-8126-116X","observed_orcids":["https://orcid.org/0000-0002-8126-116X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"B. Bittner","raw_affiliation_strings":[", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;","F Hoffmann-La Roche Ltd., Clinical Pharmacology, Grenzacher Strasse 124, CH-4070 Basel, Switzerland. beate.bittner@email.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F Hoffmann-La Roche Ltd., Clinical Pharmacology, Grenzacher Strasse 124, CH-4070 Basel, Switzerland. beate.bittner@email.de","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066034815","display_name":"Christine McIntyre","orcid":"https://orcid.org/0009-0000-6504-570X","observed_orcids":["https://orcid.org/0009-0000-6504-570X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C. McIntyre","raw_affiliation_strings":[", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045050473","display_name":"Hu Tian","orcid":"https://orcid.org/0000-0001-8686-7390","observed_orcids":["https://orcid.org/0000-0001-8686-7390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Tian","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062261970","display_name":"Kenneth Tang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Tang","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"N. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Shah","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039040446","display_name":"Wantanee Phuapradit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Phuapradit","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"H. Ahmed","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","F . Hoffmann-La Roche Ltd. , Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]},{"raw_affiliation_string":"F . Hoffmann-La Roche Ltd. , Basel , Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025791694","display_name":"Hitesh P. Chokshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Chokshi","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","University of Bath , United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]},{"raw_affiliation_string":"University of Bath , United Kingdom;","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027753889","display_name":"Martin H. Infeld","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Infeld","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072811095","display_name":"Nikoletta Fotaki","orcid":"https://orcid.org/0000-0003-1826-7363","observed_orcids":["https://orcid.org/0000-0003-1826-7363"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"N. Fotaki","raw_affiliation_strings":["Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Ma","raw_affiliation_strings":[", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Hoffmann-La Roche Inc. , Nutley , USA; Department of Pharmacy and Pharmacology 3 ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002428093","display_name":"Agn\u00e8s Portron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A. Portron","raw_affiliation_strings":[", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", F . Hoffmann-La Roche Ltd. , Basel , Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Jordan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"P. Jordan","raw_affiliation_strings":["Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053315132","display_name":"Johannes Schmidt","orcid":"https://orcid.org/0000-0002-5340-8611","observed_orcids":["https://orcid.org/0000-0002-5340-8611"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"J. Schmidt","raw_affiliation_strings":["Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Ltd. , Clinical Pharmacology , Grenzacher Strasse 124 , CH-4070 Basel , Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1518,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.51449197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"67","issue":"3","first_page":"233","last_page":"241"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.4106000065803528,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.04749999940395355,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibandronate","display_name":"ibandronate","score":1.0},{"id":"https://openalex.org/keywords/snac","display_name":"SNAC","score":0.9509999752044678},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.7390000224113464},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8130000233650208},{"id":"https://openalex.org/keywords/drug-excipient-ratio","display_name":"drug-excipient ratio","score":0.7440000176429749},{"id":"https://openalex.org/keywords/capsule-formulation","display_name":"capsule formulation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/fasting-duration","display_name":"fasting duration","score":0.7059999704360962},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.8460000157356262}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7560162544250488},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6577597856521606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.625271201133728},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5890387296676636},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47851479053497314},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.4359617829322815},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43247249722480774}],"mesh":[{"descriptor_ui":"D000077557","descriptor_name":"Ibandronic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002210","descriptor_name":"Caprylates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.31083/ph.2012.1648","doi":"https://doi.org/10.31083/ph.2012.1648","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2012.1648","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/67_03_S233_241.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},{"id":"pmid:22530305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22530305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Clinical Trial, Phase I"},{"id":"mag:2809975487","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201202257342409383","pdf_url":null,"source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Pharmazie","raw_type":null},{"id":"mag:47093099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22530305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.31083/ph.2012.1648","doi":"https://doi.org/10.31083/ph.2012.1648","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2012.1648","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/67_03_S233_241.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W47093099.pdf","grobid_xml":"https://content.openalex.org/works/W47093099.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W137260574","https://openalex.org/W171225673","https://openalex.org/W186541353","https://openalex.org/W1554225201","https://openalex.org/W1559041956","https://openalex.org/W1989616697","https://openalex.org/W1990526206","https://openalex.org/W1997758050","https://openalex.org/W2003097465","https://openalex.org/W2024412436","https://openalex.org/W2035190861","https://openalex.org/W2049146115","https://openalex.org/W2099054178","https://openalex.org/W2109465803"],"related_works":["https://openalex.org/W1964782762","https://openalex.org/W2313512076","https://openalex.org/W3021667657","https://openalex.org/W4206439467","https://openalex.org/W7163423009","https://openalex.org/W3190878055","https://openalex.org/W7213439933","https://openalex.org/W4386055584","https://openalex.org/W3020287162","https://openalex.org/W3040407899"],"abstract_inverted_index":{"The":[0,100,175],"aim":[1],"of":[2,21,31,46,59,67,118,123,177,199],"this":[3],"study":[4],"was":[5,48,105,184],"to":[6,75,132,148,186,201],"select":[7],"a":[8,88,93,108,153,169],"novel":[9],"oral":[10,54,78],"formulation":[11,110],"for":[12],"ibandronate":[13,60],"(IBN,":[14],"CAS":[15,40],"number:":[16,41],"13892619).":[17],"In":[18],"four":[19],"cohorts":[20,183],"28,":[22],"21,":[23],"19":[24],"and":[25,63,71,83,92,114,121,128,171,193],"29":[26],"healthy":[27],"volunteers,":[28],"the":[29,32,44,76,98,133,142,178,189],"impact":[30],"carrier":[33],"molecule":[34],"sodium":[35],"N-[8-(2-hydroxybenzoyl)":[36],"amino]":[37],"caprylate":[38],"(SNAC,":[39],"203787-91-1)":[42],"on":[43],"bioavailability":[45],"IBN":[47,79,103,124,138,162,190],"investigated.":[49],"Within":[50],"each":[51],"cohort":[52],"different":[53,65],"formulations":[55,81],"with":[56,107],"one":[57,94],"dose":[58],"(30":[61],"mg)":[62],"three":[64],"ratios":[66],"IBN:SNAC":[68,116],"(1:5,":[69],"1:10":[70],"1:20)":[72],"were":[73,125,166,198],"compared":[74,131],"approved":[77],"tablet":[80],"(150":[82,136],"50":[84],"mg":[85,137],"IBN)":[86],"in":[87,152,158,181,188],"4-way":[89],"cross-over":[90],"design":[91],"week":[95],"washout":[96],"between":[97],"administrations.":[99],"highest":[101],"mean":[102],"exposure":[104],"achieved":[106,167],"capsule":[109],"containing":[111],"drug-coated":[112],"beadlets":[113],"an":[115],"ratio":[117],"1:5.":[119],"AUC(last)":[120],"C(max)":[122],"approximately":[126],"1.3-":[127],"2.2-fold":[129],"higher":[130],"reference":[134,191],"treatment":[135],"without":[139],"SNAC).":[140],"Increasing":[141],"post-dose":[143],"fasting":[144],"duration":[145],"from":[146],"15":[147],"30":[149,170],"min":[150,173],"resulted":[151],"more":[154],"than":[155],"2-fold":[156],"increase":[157],"AUC(last),":[159],"while":[160],"superimposable":[161],"serum":[163],"concentration-time":[164],"profiles":[165],"after":[168],"60":[172],"fast.":[174],"tolerability":[176],"IBN/SNAC":[179],"treatments":[180],"all":[182],"similar":[185],"that":[187],"groups":[192],"most":[194],"adverse":[195],"events":[196],"(AEs)":[197],"mild":[200],"moderate":[202],"intensity.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W47093099","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
